Who Exports Protein from India — 228 Suppliers Behind a $14.9M Market
India's protein export market is supplied by 228 active exporters who collectively shipped $14.9M across 1,352 shipments. PANACEA BIOTEC PHARMA LIMITED leads with a 38.6% market share, followed by KARDI TRADING PRIVATE LIMITED and GETWELL PHARMA INDIA PRIVATE LIMITED. The top 5 suppliers together control 73.2% of total export value, reflecting a concentrated market structure.
Top Protein Exporters from India — Ranked by Export Value
PANACEA BIOTEC PHARMA LIMITED is the leading protein exporter from India, holding a 38.6% share of the $14.9M market across 1,352 shipments from 228 exporters. The top 5 suppliers — PANACEA BIOTEC PHARMA LIMITED, KARDI TRADING PRIVATE LIMITED, GETWELL PHARMA INDIA PRIVATE LIMITED, ADVY CHEMICAL PRIVATE LIMITED, CIPLA LIMITED — collectively control 73.2% of total export value, indicating a highly concentrated market. Individual shares are: PANACEA BIOTEC PHARMA LIMITED (38.6%), KARDI TRADING PRIVATE LIMITED (14.0%), GETWELL PHARMA INDIA PRIVATE LIMITED (9.5%), ADVY CHEMICAL PRIVATE LIMITED (7.7%), CIPLA LIMITED (3.4%).
Top Protein Exporters from India
Ranked by export value · 228 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | PANACEA BIOTEC PHARMA LIMITED CIPLA PACLITAXEL 100MG PER VIAL)[P/S:1X50ML]PACLITAXEL B/N.907024024 M/D.01/2025 E/D.12/2026.CIPLA PACLITAXEL ,100MG PER VIAL) | $5.7M | 14 | 38.6% |
| 2 | KARDI TRADING PRIVATE LIMITED PALIT SPAL 100MG (PACLITAXEL PROTEINDIAGNOSTIC REAGENTS C REACTIVE PROTEINPALIT SPAL 100MG 1S (1340 PACKS | $2.1M | 6 | 14.0% |
| 3 | GETWELL PHARMA INDIA PRIVATE LIMITED ALPAXEL 100MG (PACLITAXEL (PROTEIN BOUND | $1.4M | 5 | 9.5% |
| 4 | ADVY CHEMICAL PRIVATE LIMITED DIAGNOSTIC REAGENTS C REACTIVE PROTEINABRAXANE100MG/V)RECOMBINANT PROTEINVLS | $1.1M | 10 | 7.7% |
| 5 | CIPLA LIMITED CIPLA PACLITAXEL 100MG PER VIAL)[P/S:1X50ML]CIPLA PACLITAXEL ,100MG PER VIAL)ABRAXANE100MG/V) | $509.3K | 3 | 3.4% |
| 6 | GETWELL PHARMACEUTICALS ALPAXEL 100MG (PACLITAXEL (PROTEIN BOUND | $375.3K | 3 | 2.5% |
| 7 | SP ACCURE LABS PRIVATE LIMITED ABRAXANE100MG/V)RECOMBINANT PROTEINVLSSARS-COV-2 RS PROTEIN COVID 19 | $362.4K | 5 | 2.4% |
| 8 | ZEST PHARMA | $186.8K | 3 | 1.3% |
| 9 | SYNAPSE PHARMATECH | $160.6K | 2 | 1.1% |
| 10 | VINDHYA INTERNATIONAL | $131.8K | 2 | 0.9% |
| 11 | SYNGENE INTERNATIONAL LIMITED PACLITAXEL B/N.907024024 M/D.01/2025 E/D.12/2026.PACLITAXEL (PROTEIN BOUND PARTICLES FORPACLITAXEL B/N.907023022 M/D.03/2024 E/D.02/2026. | $127.1K | 9 | 0.9% |
| 12 | GENEX PHARMA CIPLA PACLITAXEL 100MG PER VIAL)[P/S:1X50ML]CIPLA PACLITAXEL ,100MG PER VIAL)ABRAXANE100MG/V) | $108.7K | 3 | 0.7% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Protein exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Panacea Biotec Pharma Limited | Not Listed | Yes | No | Not verified | Panacea Biotec is a major vaccine manufacturer in India, with WHO prequalified v |
| Cipla Limited | Approved | Yes | No | Multiple | Cipla has received FDA approvals for various generic drugs, including Esomeprazo |
| Advy Chemical Private Limited | Not Listed | No | No | Not verified | Advy Chemical's President of Quality and Pharmacovigilance participated in the W |
| Synapse Pharmatech | Warning Letter, June 2024 | No | No | Not verified | FDA deemed clinical and bioanalytical studies by Synapse Labs unacceptable due t |
| Vindhya International | Not Listed | No | No | Not verified | Vindhya Pharma, a subsidiary of Viyash Life Sciences, is involved in API and int |
| SP Accure Labs Private Limited | Not Listed | Yes | No | Not verified | SP Accure Labs is listed among manufacturers with WHO GMP certification. |
| Zest Pharma | Not Listed | Yes | No | Not verified | Zest Pharma is listed among manufacturers with WHO GMP certification. |
| Genex Pharma | Not Listed | Yes | No | Not verified | Genex Pharma is listed among manufacturers with WHO GMP certification. |
TransData Nexus reviewed the regulatory standing of 8 leading Protein exporters from India. 1 hold US FDA facility approvals, 5 maintain WHO-GMP certification, and 0 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Protein sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for active pharmaceutical ingredients (APIs) and bulk drug manufacturing. The city hosts Genome Valley, India's first biotech cluster, which is home to over 800 pharmaceutical companies, including industry leaders like Dr. Reddy's Laboratories and Aurobindo Pharma. This concentration fosters a robust ecosystem for API production, essential for protein-based pharmaceuticals. The Telangana government's initiative to develop the Hyderabad Pharma City aims to further consolidate the region's position by integrating APIs, formulations, and support services within a unified infrastructure.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its prowess in pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production, with over 3,300 pharma units operating in the state. Major companies such as Zydus Lifesciences and Cadila Pharmaceuticals are headquartered here, leveraging the region's strong support infrastructure, including ports, roads, and power facilities. This environment is conducive to the development and export of complex protein formulations.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates seamless international trade, making it an ideal location for companies focusing on exports. The region's well-established infrastructure and proximity to international shipping routes enhance its role in the global distribution of pharmaceutical products, including protein-based drugs.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi, located in Himachal Pradesh, has emerged as Asia's largest pharmaceutical manufacturing hub, housing over 1,000 pharma companies. The region's growth was significantly propelled by tax incentives and government support initiated in the early 2000s. Companies like Cipla and Dr. Reddy's Laboratories have established substantial operations here, contributing to the production and export of various pharmaceutical products.
5Sourcing Recommendations
- Diversify Supplier Base: Given that the top five exporters account for 73.2% of protein exports, it's advisable to explore partnerships with emerging suppliers to mitigate dependency risks.
- Leverage Regional Specializations: Align sourcing strategies with regional strengths—procure APIs from Hyderabad, formulations from Ahmedabad-Vadodara, and utilize Mumbai's export infrastructure for efficient distribution.
- Monitor Regulatory Compliance: Ensure that suppliers adhere to international quality standards and regulatory requirements, particularly when exporting to stringent markets like the United States and Canada.
- Assess Infrastructure and Logistics: Evaluate the logistical capabilities of each region, considering factors such as proximity to ports, transportation networks, and supply chain reliability to optimize sourcing decisions.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Protein exporters from India
PANACEA BIOTEC PHARMA LIMITED — Panacea Biotec forms U.S. subsidiary to enter American healthcare market
Panacea Biotec Pharma Limited established a wholly-owned subsidiary, Panacea Biotec Inc., in the United States. This strategic move aims to penetrate the U.S. healthcare market by engaging in activities such as buying, selling, marketing, importing, exporting, distributing, and dealing in health and wellness products, including nutrition, dietary supplements, OTC drugs, medical devices, prescription drugs, and vaccines. - IMPACT: This expansion is expected to enhance Panacea Biotec's global footprint, potentially increasing protein exports to the U.S. market.
Impact: This expansion is expected to enhance Panacea Biotec's global footprint, potentially increasing protein exports to the U.S. market.
Common Questions — Protein Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which protein supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, PANACEA BIOTEC PHARMA LIMITED leads with 60 recorded shipments worth $5.7M. KARDI TRADING PRIVATE LIMITED (58 shipments) and GETWELL PHARMA INDIA PRIVATE LIMITED (30 shipments) are also established high-volume exporters.
Q How many protein manufacturers are there in India?
India has 228 active protein exporters with a combined export market of $14.9M across 1,352 shipments to 110 countries. The top 5 suppliers hold 73.2% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for protein from India?
Average FOB unit price: $1866.12 per unit, ranging from $0.00 to $87347.53. Average shipment value: $11.0K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 228 verified Indian exporters of Protein ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,352 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 110 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,352 Verified Shipments
228 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists